Skip to main content

Halozyme Therapeutic (NQ: HALO )

40.73 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 27, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
January 06, 2015
Form 8-K/A
Source: SEC/Edgar
January 06, 2015
Form 8-K
Source: SEC/Edgar
November 09, 2014
Form 8-K
Source: SEC/Edgar
October 23, 2014
Form 8-K
Source: SEC/Edgar
August 10, 2014
Form SC 13G
Source: SEC/Edgar
August 06, 2014
Form 8-K
Source: SEC/Edgar
May 15, 2014
Form 8-K
Source: SEC/Edgar
May 11, 2014
Form DEF 14A
Source: SEC/Edgar
April 06, 2014
Form 8-K
Source: SEC/Edgar
April 02, 2014
Form 8-K
Source: SEC/Edgar
February 26, 2014
Form SC 13G
Source: SEC/Edgar
February 13, 2014
Form SC 13G/A
Source: SEC/Edgar
February 11, 2014
Form 8-K
Source: SEC/Edgar
February 04, 2014
Form 424B5
Source: SEC/Edgar
February 04, 2014
Form 424B5
Source: SEC/Edgar
February 02, 2014
Form SC 13G
Source: SEC/Edgar
January 28, 2014
Form 8-K
Source: SEC/Edgar
January 12, 2014
Form 8-K
Source: SEC/Edgar
January 02, 2014
Form CT ORDER
Source: SEC/Edgar
December 30, 2013
Form 8-K
Source: SEC/Edgar
December 17, 2013
Form 8-K
Source: SEC/Edgar
November 07, 2013
Form 8-K
Source: SEC/Edgar
October 30, 2013
Form SC 13G
Source: SEC/Edgar
August 13, 2013
Form 8-K
Source: SEC/Edgar
August 06, 2013
Form 8-K
Source: SEC/Edgar
July 02, 2013
Form S-8
Source: SEC/Edgar
May 30, 2013
Form 8-K
Source: SEC/Edgar
May 23, 2013
Form 8-K
Source: SEC/Edgar
May 16, 2013
Form 8-K
Source: SEC/Edgar
May 07, 2013
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.